Atıf Formatları
Optimization of the Novel Antiviral Drug Molnupiravir by LC-ESI-MS/MS
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. DARI Et Al. , "Optimization of the Novel Antiviral Drug Molnupiravir by LC-ESI-MS/MS," 33rd International Symposium on Pharmaceuticals and Biomedical Analysis , Ankara, Turkey, 2023

DARI, Y. Et Al. 2023. Optimization of the Novel Antiviral Drug Molnupiravir by LC-ESI-MS/MS. 33rd International Symposium on Pharmaceuticals and Biomedical Analysis , (Ankara, Turkey).

DARI, Y., DİNCEL, D., ŞENER, E., & AK, D., (2023). Optimization of the Novel Antiviral Drug Molnupiravir by LC-ESI-MS/MS . 33rd International Symposium on Pharmaceuticals and Biomedical Analysis, Ankara, Turkey

DARI, YASİN Et Al. "Optimization of the Novel Antiviral Drug Molnupiravir by LC-ESI-MS/MS," 33rd International Symposium on Pharmaceuticals and Biomedical Analysis, Ankara, Turkey, 2023

DARI, YASİN Et Al. "Optimization of the Novel Antiviral Drug Molnupiravir by LC-ESI-MS/MS." 33rd International Symposium on Pharmaceuticals and Biomedical Analysis , Ankara, Turkey, 2023

DARI, Y. Et Al. (2023) . "Optimization of the Novel Antiviral Drug Molnupiravir by LC-ESI-MS/MS." 33rd International Symposium on Pharmaceuticals and Biomedical Analysis , Ankara, Turkey.

@conferencepaper{conferencepaper, author={YASİN DARI Et Al. }, title={Optimization of the Novel Antiviral Drug Molnupiravir by LC-ESI-MS/MS}, congress name={33rd International Symposium on Pharmaceuticals and Biomedical Analysis}, city={Ankara}, country={Turkey}, year={2023}}